Why the study?
Does genetically increased lipoprotein secretion prevent development of obesity-induced lipotoxic heart disease in mice?
Does genetically increased lipoprotein secretion prevent development of obesity-induced lipotoxic heart disease in mice?
Genetically increased lipoprotein secretion prevents the development of obesity-induced lipotoxic heart disease in mouse models.
No takes yet. Share an insight, caveat, or question.
Does not alter clinical practice; leaves open whether apoB-mediated triglyceride clearance prevents human lipotoxic cardiomyopathy.
Bartels et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: